158 related articles for article (PubMed ID: 8864733)
1. Expression of galectins in head and neck squamous cell carcinoma.
Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
3. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
4. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
[TBL] [Abstract][Full Text] [Related]
7. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
[TBL] [Abstract][Full Text] [Related]
8. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
Xu XC; el-Naggar AK; Lotan R
Am J Pathol; 1995 Sep; 147(3):815-22. PubMed ID: 7677193
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
11. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
12. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
15. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.
Sheikholeslam-Zadeh R; Decaestecker C; Delbrouck C; Danguy A; Salmon I; Zick Y; Kaltner H; Hassid S; Gabius HJ; Kiss R; Choufani G
Laryngoscope; 2001 Jun; 111(6):1042-7. PubMed ID: 11404618
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
[TBL] [Abstract][Full Text] [Related]
17. Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer.
Chovanec M; Smetana K; Betka J; Plzák J; Brabec J; Moya-Alvarez V; André S; Kodet R; Gabius HJ
Int J Oncol; 2005 Aug; 27(2):409-15. PubMed ID: 16010422
[TBL] [Abstract][Full Text] [Related]
18. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and microarray gene expression analysis of tri-dimensional raft-modeled human head and neck squamous cell carcinoma.
Zanation AM; Yin X; Shores C; Yarbrough WG
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):577-84. PubMed ID: 15523429
[TBL] [Abstract][Full Text] [Related]
20. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
